Jefferies Group LLC Edwards Lifesciences Corp Call Options Transaction History

Jefferies Group LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $10.8 Million - $13.7 Million	-106,400 Closed	0 $0
Q4 2021 Sep 21, 2023	BUY	$106.37 - $130.68 $11.3 Million - $13.9 Million	106,400 New	106,400 $13.8 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $11.3 Million - $13.9 Million	106,400 New	106,400 $13.8 Million
Q2 2020 Aug 14, 2020	SELL	$57.54 - $76.95 $276,192 - $369,360	-4,800 Closed	0 $0
Q1 2020 Nov 24, 2020	SELL	$52.41 - $81.0 $335,424 - $518,400	-6,400 Reduced 57.14%	4,800 $941,000

Q3 2019 Nov 13, 2019	SELL	$61.55 - $75.43 $9.54 Million - $11.7 Million	-155,000 Reduced 93.26%	11,200 $2.46 Million
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $7.69 Million - $10.3 Million	160,600 Added 2867.86%	166,200 $31.8 Million
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $1.32 Million - $1.68 Million	-28,900 Reduced 83.77%	5,600 $975,000
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $1.46 Million - $1.77 Million	34,500 New	34,500 $5.02 Million

1,377

454M

3.86M

3.32M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $56.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.